Results From Phase 2 Registration Trial Of Sl-401 In Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (Bpdcn): Lead-In Completed, Expansion Stage Ongoing.
JOURNAL OF CLINICAL ONCOLOGY(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2016)